Cargando…

10,21-Dimethyl-2,7,13,18-tetraphenyl-3,6,14,17-tetraazatricyclo[17.3.1.1(8,12)]tetracosa-1(23),2,6,8(24),9,11,13,17,19,21-decaene-23,24-diol cyclohexane 0.33-solvate

The title compound, C(46)H(40)N(4)O(2)·0.33C(6)H(12), was obtained unintentionally as a product of an attempted synthesis of a cadmium(II) complex of the [2,6-{PhSe(CH(2))(2)N=CPh}(2)C(6)H(2)(4-Me)(OH)] ligand. The full tetraiminodiphenol macrocyclic ligand is generated by the application of an in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asatkar, Ashish K., Verma, Vinay K., Jain, Tripti A., Singh, Rajendra, Gupta, Sushil K., Butcher, Ray J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Union of Crystallography 2011
Materias:	Organic Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201359/ https://www.ncbi.nlm.nih.gov/pubmed/22065495 http://dx.doi.org/10.1107/S1600536811036622

Ejemplares similares

Dichlorido[μ-10,21-dimethyl-2,7,13,18-tetraphenyl-3,6,14,17-tetraazatricyclo[17.3.1.1(8,12)]tetracosa-1(23),2,6,8,10,12(24),13,17,19,21-decaene-23,24-diolato]dicopper(II) ethanol hemisolvate dihydrate
por: Gupta, Sushil K., et al.
Publicado: (2010)

[μ-10,21-Dimethyl-3,6,14,17-tetrazatricyclo[17.3.1.1(8,12)]tetracosa-1(23),2,6,8,10,12 (24),13,17,19,21-decaene-23,24-diolato-κ(4) N (3),N (6),O (23),O (24):κ(4) N (14),N (17),O (23),O (24)]bis(perchlorato-κO)dimanganese(II)
por: Liu, Jing, et al.
Publicado: (2008)

[μ-10,21-Dimethyl-3,6,14,17-tetraazatricyclo[17.3.1.1(8,12)]tetracosa-1(23),8(24),9,11,19,21-hexaene-23,24-diolato-κ(8) N (3),N (6),O (23),O (24):N (14),N (17),O (23),O (24)]bis[(nitrato-κ(2) O,O′)nickel(II)]
por: Li, Quan-Jun, et al.
Publicado: (2009)

[μ-(4S,5S,15S,16S)-10,21-Di-tert-butyl-4,5,15,16-tetraphenyl-3,6,14,17-tetraazatricyclo[17.3.1.1(8,12)]tetracosa-1(23),8,10,12(24),19,21-hexaene-23,24-diolato-κ(8) N (3),N (6),O (23),O (24):N (14) N (17),O (23),O (24)]bis[(acetato-κO)zinc(II)] ethanol disolvate
por: Fan, Li-Jing, et al.
Publicado: (2009)

3,6,14,17-Tetramethoxy-22,23-diphenyl-1,10,12,21-tetraazahexacyclo[19.2.1.0(2,7).0(10,23).0(12,22).0(13,18)]tetracosa-2(7),3,5,13(18),14,16-hexaene-11,24-dithione
por: Yang, Yan
Publicado: (2010)

Diethyl 6,9,17,20-tetrabromo-2,13-dioxohexacyclo[10.10.2.0(3,24).0(5,10).0(14,23).0(16,21)]tetracosa-5,7,9,16,18,20-hexaene-23,24-dicarboxylate
por: Zhu, Yanping, et al.
Publicado: (2009)

Diethyl 7,8,18,19-tetramethyl-2,13-dioxohexacyclo[10.10.2.0(3,24).0(5,10).0(14,23).0(16,21)]tetracosa-5,7,9,16,18,20-hexaene-23,24-dicarboxylate
por: Wang, Jungang, et al.
Publicado: (2010)

Unraveling and engineering the production of 23,24-bisnorcholenic steroids in sterol metabolism
por: Xu, Li-Qin, et al.
Publicado: (2016)

2,2,7,7,12,12,17,17-Octamethyl-21,22,23,24-tetrathia-2,7,12,17-tetragermapentacyclo[16.2.1.1(3,6).1(8,11).1(13,16)]tetracosa-3,5,8,10,13,15,18,20-octaene
por: Carel, Guillaume, et al.
Publicado: (2012)

11-(p-Tolylsulfonyl)-8,14,24-trioxa-11,22,23-triazatetracyclo[19.2.1.0(2,7).0(15,20)]tetracosa-1(23),2,4,6,15,17,19,21-octaene
por: Tian, Xia, et al.
Publicado: (2009)

PS status report No. 247: Period 17.5.1976 - 19.6.1976 (Weeks 21,22,23,24,25)
por: Asboe-Hansen, P
Publicado: (1976)

23,24-Dihydrocucurbitacin B promotes lipid clearance by dual transcriptional regulation of LDLR and PCSK9
por: Li, Hui-hui, et al.
Publicado: (2019)

Runs 22, 23, 24, 25 on February 12, 15 and 17 1971
por: Knezovic, A, et al.
Publicado: (1971)

8,11,24-Trioxa-21-thia-19-azapentacyclo[16.6.0.0(2,7).0(12,17).0(19,23)]tetracosa-2(7),3,5,12,14,16-hexaene
por: Devi, Seenivasan Karthiga, et al.
Publicado: (2013)

Pump down of sectors 24/01 and sectors 13 to 23
por: Malthouse, H F, et al.
Publicado: (1983)

Compte rendu des tests partiels sur le PS du 21 février 1979 de 17.30h à 24.00h et du 23 février 1979 de 17.30h à 21.00h
por: Cornuet, D
Publicado: (1979)

25,26-Bis(propan-2-ylidene)heptacyclo[20.2.1.1(10,13).0(2,21).0(3,8).0(9,14).0(15,20)]hexacosa-2(21),3,5,7,9(14),11,15,17,19,23-decaene
por: Cooper, Stefan M., et al.
Publicado: (2012)

2,15-Dioxa-7,18,19,20,23-pentaazaheptacyclo[21.6.1.1(17,20).0(1,8).0(3,7).0(9,14).0(24,29)]hentriaconta-9,11,13,17(31),18,24,26,28-octaen-30-one
por: Subhashree, Govindarajulu Rangabashyam, et al.
Publicado: (2013)

(E)-17β,19-Epoxymethano-17,23,24-tridemethyl-4-nor-5β,18α-olean-3-one oxime
por: Froelich, Anna, et al.
Publicado: (2009)

Identification of 16,25-O-diacetyl-cucurbitane F and 25-O-acetyl-23,24-dihydrocucurbitacin F as novel anti-cancer chemicals
por: Wang, Wenxue, et al.
Publicado: (2018)

The Inhibition of Gastric Cancer Cells’ Progression by 23,24-Dihydrocucurbitacin E through Disruption of the Ras/Raf/ERK/MMP9 Signaling Pathway
por: Liu, Huiping, et al.
Publicado: (2022)

Common polymorphic inversions at 17q21.31 and 8p23.1 associate with cancer prognosis
por: Ruiz-Arenas, Carlos, et al.
Publicado: (2019)

The Roles of IL-17, IL-21, and IL-23 in the Helicobacter pylori Infection and Gastrointestinal Inflammation: A Review
por: Dewayani, Astri, et al.
Publicado: (2021)

11-[(E)-Benzylidene]-14-hydroxy-8-phenyl-3,13-diazaheptacyclo[13.7.1.1(9,13).0(2,9).0(2,14).0(3,7).0(19,23)]tetracosa-1(22),15,17,19(23),20-pentaen-10-one
por: Kumar, Raju Suresh, et al.
Publicado: (2010)

Miller-Dieker Syndrome with der(17)t(12;17)(q24.33;p13.3)pat Presenting with a Potential Risk of Mis-identification as a de novo Submicroscopic Deletion of 17p13.3
por: Kim, Young Jin, et al.
Publicado: (2011)

Interleukin-17A and interleukin-23 in morphea
por: Dańczak-Pazdrowska, Aleksandra, et al.
Publicado: (2012)

Interleukins 17 and 23 in patients with gastric neoplasms
por: Błogowski, Wojciech, et al.
Publicado: (2016)

Effect of interleukin-6, -17, -21, -22, and -23 and STAT3 on signal transduction pathways and their inhibition in autoimmune arthritis
por: Woś, Izabela, et al.
Publicado: (2021)

11-[(E)-4-Bromobenzylidene]-8-(4-bromophenyl)-14-hydroxy-3,13-diazaheptacyclo[13.7.1.1(9,13).0(2,9).0(2,14).0(3,7).0(19,23)]tetracosa-1(22),15,17,19(23),20-pentaen-10-one
por: Kumar, Raju Suresh, et al.
Publicado: (2010)

Diaqua[μ-11,23-di-tert-butyl-3,7,15,19-tetraazatricyclo[19.3.1.1(9,13)]tetracosa-1(25),2,6,9,11,13(26),14,19,21,23-dodecaene-25,26-diolato-κ(4) N (3),N (7),O (25),O (26):κ(4) N (15),N (19),O (25),O (26)]dicopper(II) bis(perchlorate)
por: Xu, Qiang, et al.
Publicado: (2012)

MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma
por: Hirata, Yukihiro, et al.
Publicado: (2014)

IL-23 and Th17 Disease in Inflammatory Arthritis
por: Yago, Toru, et al.
Publicado: (2017)

Erratum, Volume 17, July 23, 2020 Release
Publicado: (2020)

Loss of heterozygosity for chromosomal regions 15q14-21.1, 17q21.31, and 13q12.3-13.1 and its relevance for prostate cancer
por: Nowacka-Zawisza, Maria, et al.
Publicado: (2015)

Canadian Spine Society: 21st Annual Virtual Scientific Conference, Feb. 3, 10, 15, 17 and 24, 2021
Publicado: (2021)

Improving the production of 22-hydroxy-23,24-bisnorchol-4-ene-3-one from sterols in Mycobacterium neoaurum by increasing cell permeability and modifying multiple genes
por: Xiong, Liang-Bin, et al.
Publicado: (2017)

Anticancer activity of 23,24-dihydrocucurbitacin B against the HeLa human cervical cell line is due to apoptosis and G2/M cell cycle arrest
por: Zhang, Jun-Xiao, et al.
Publicado: (2021)

Clinical Significance of IL-23 Regulating IL-17A and/or IL-17F Positive Th17 Cells in Chronic Periodontitis
por: Luo, Zhenhua, et al.
Publicado: (2014)

MON-917 Carney Complex Due to a Contiguous Gene Deletion Syndrome (17q24.2-17q24.3)
por: Flippo, Chelsi L, et al.
Publicado: (2020)

Regulatory effects of C5a on IL-17A, IL-17F, and IL-23
por: Grailer, Jamison J., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_psvv8jjv0ms7fa0snf3d0s3220